Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on InMode (INMD – Research Report), Trupanion (TRUP – Research Report) and Regeneron (REGN – Research Report).
InMode (INMD)
In a report released yesterday, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on InMode, with a price target of $22.00. The company’s shares closed last Thursday at $21.76, close to its 52-week low of $18.57.
Currently, the analyst consensus on InMode is a Moderate Buy with an average price target of $30.75, representing a 46.4% upside. In a report released today, UBS also downgraded the stock to Hold with a $24.00 price target.
See today’s best-performing stocks on TipRanks >>
Trupanion (TRUP)
Canaccord Genuity analyst Maria Ripps maintained a Buy rating on Trupanion yesterday and set a price target of $40.00. The company’s shares closed last Thursday at $22.87, close to its 52-week low of $18.45.
According to TipRanks.com, Ripps is a 5-star analyst with an average return of
Currently, the analyst consensus on Trupanion is a Moderate Buy with an average price target of $37.17.
Regeneron (REGN)
In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Regeneron, with a price target of $1066.00. The company’s shares closed last Thursday at $818.79.
According to TipRanks.com, Newman is a 5-star analyst with an average return of
Currently, the analyst consensus on Regeneron is a Strong Buy with an average price target of $922.94, implying a 16.6% upside from current levels. In a report released yesterday, Raymond James also upgraded the stock to Buy with a $950.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on INMD:
- InMode Reports Third Quarter 2023 Financial Results; Quarterly Revenue of $123.1M Represents 2% Year-Over-Year Growth
- 5 Top Small-Cap Stocks to Buy Now, According to Analysts – October 2023
- InMode files patent infringement suit against BTL Industries
- InMode price target lowered to $32 from $61 at Baird
- InMode downgraded to Hold from Buy at Canaccord
